During the vaccination of the population in San Marino, the Russian private equity fund, the investor of the Russian vaccine against the coronavirus Sputnik V, announced positive results on the safety of the drug.
This is reported in the journal EClinicalMedicine.
The Foundation notes that a related study on the safety of the vaccine was conducted in San Marino from March 4 to April 8, 2021. The experts quantified the incidence of adverse events after immunization with the first and two components.
No deaths or hospitalizations were reported. Nearly all vaccine-related adverse events were mild to moderate and / or lasting less than two days.